USANA Health Sciences, Inc. (USNA): Análisis PESTLE [Actualizado en Ene-2025]

En el mundo dinámico de los suplementos nutricionales, USANA Health Sciences, Inc. (USNA) se encuentra en una intersección crítica de desafíos y oportunidades globales. Este análisis integral de mano de mortero profundiza en el panorama multifacético que da forma al posicionamiento estratégico de la compañía, revelando cómo las tensiones políticas, los cambios económicos, las tendencias sociales, las innovaciones tecnológicas, las complejidades legales y las consideraciones ambientales convergen para influir en el ecosistema comercial de USANA. Descubra la intrincada red de factores externos que determinarán la resistencia y el potencial de crecimiento de la compañía en un mercado de salud y bienestar cada vez más competitivo y sofisticado.

USANA Health Sciences, Inc. (USNA) - Análisis de mortero: factores políticos

El impacto en las tensiones comerciales de US-China en las cadenas de suministro global de suplementos

A partir de 2024, las tensiones comerciales de US-China han afectado directamente las cadenas de suministro de suplementos dietéticos con 25% de aranceles sobre ingredientes nutricionales importados chinos. El conflicto comercial ha resultado en importantes interrupciones de la cadena de suministro para USANA.

Métrica de impacto comercial	Valor cuantitativo
Tasa de tarifa en los suplementos chinos	25%
Aumento estimado de costos de la cadena de suministro	17.3%
Tasa de diversificación de abastecimiento de ingredientes	42%

Aumento del escrutinio regulatorio en las reclamaciones de marketing de suplementos dietéticos

La Comisión Federal de Comercio (FTC) ha aumentado las acciones de cumplimiento contra las compañías de suplementos, con $ 68.3 millones en acuerdos relacionados con reclamos de salud sin fundamento en 2023.

• Acciones de cumplimiento de la FTC: 47 casos en 2023
• Monto promedio de la liquidación: $ 1.45 millones
• Categorías de violación primaria:
  • Reclamos de salud no probados
  • Publicidad engañosa
  • Evidencia científica insuficiente

Cambios potenciales en las regulaciones de la FDA

La FDA propuso nuevas regulaciones de suplementos dietéticos en 2024, lo que puede afectar los requisitos de cumplimiento del producto de USANA.

Propuesta regulatoria	Impacto potencial
Verificación de ingredientes mejorados	Aumento de requisitos de prueba
Informes de eventos adversos obligatorios	Protocolos de documentación más estrictos
Expansión de registro de productos	Costos de cumplimiento adicionales

Debates de política de salud continuas

Las discusiones de políticas de salud en 2024 continúan influyendo en el mercado de suplementos dietéticos, con $ 42.6 mil millones en la industria total de suplementos Impacto económico.

• Audiencias del Congreso sobre la regulación de los suplementos: 3 sesiones principales en 2024
• Áreas clave de discusión de políticas:
  • Protección al consumidor
  • Sustanciación científica
  • Normas de fabricación

USANA Health Sciences, Inc. (USNA) - Análisis de mortero: factores económicos

Fluctuando ingresos disponibles al consumidor que afectan las compras de productos de salud

Los ingresos de USANA en 2023 fueron de $ 1.13 mil millones, con una disminución del 4.3% de 2022. El ingreso disponible promedio de los hogares en los mercados clave mostró variaciones:

País	Cambio de ingresos disponibles (2023)
Estados Unidos	+2.1%
Porcelana	-0.5%
Canadá	+1.7%
Australia	+1.3%

Incertidumbre económica global que impacta el modelo de negocio de venta directa

Tendencias globales del mercado de venta directa:

• Tamaño del mercado de ventas directas globales en 2023: $ 186.1 mil millones
• Ingresos del mercado internacional de USANA: $ 712.4 millones
• Tasa de crecimiento del mercado: 3.2%

Expansión del mercado potencial en economías emergentes

Mercado emergente	Tasa de crecimiento de la clase media	Penetración del mercado de USANA
India	8.5%	5.2%
Sudeste de Asia	6.7%	3.8%
Brasil	4.3%	2.9%

Volatilidad del tipo de cambio de divisas

Impacto en la moneda en los ingresos de USANA:

Divisa	Fluctuación del tipo de cambio (2023)	Impacto de ingresos
Yuan chino	-3.2%	Reducción de $ 24.6 millones
Dólar australiano	-1.8%	Reducción de $ 12.4 millones
Dólar canadiense	-1.5%	Reducción de $ 9.7 millones

USANA Health Sciences, Inc. (USNA) - Análisis de mortero: factores sociales

Creciente interés del consumidor en la atención médica y bienestar preventivos

Según el Global Wellness Institute, la economía de bienestar global se valoró en $ 4.9 billones en 2019, con una atención médica preventiva que representa un segmento significativo. El mercado de salud preventiva de EE. UU. Se estimó en $ 3.2 billones en 2021.

Segmento de mercado	Valor de mercado (2021)	Tasa de crecimiento anual
Atención médica preventiva	$ 3.2 billones	6.2%
Productos de bienestar	$ 1.5 billones	5.8%

Aumento de la demanda de suplementos personalizados de nutrición y salud

El mercado global de nutrición personalizada se valoró en $ 12.8 mil millones en 2022, con un crecimiento proyectado a $ 26.5 mil millones para 2027.

Segmento de mercado	Valor 2022	2027 Valor proyectado	Tocón
Nutrición personalizada	$ 12.8 mil millones	$ 26.5 mil millones	15.7%

Envejecimiento de la población que busca el apoyo nutricional y los productos de bienestar

Para 2030, 1 de cada 5 residentes estadounidenses tendrán 65 años o más. Se espera que la población de más de 65 años alcance los 74.1 millones para 2030.

Grupo de edad	2020 población	2030 Población proyectada	Porcentaje de crecimiento
Más de 65 años	54.1 millones	74.1 millones	36.9%

Creciente conciencia de salud entre los millennials y los consumidores de la generación Z

El 76% de los millennials informan que se centran en la salud y el bienestar, con un 68% dispuesto a gastar más en productos relacionados con la salud.

Grupo de consumo	Porcentaje de enfoque de salud	Voluntad de gastar más
Millennials	76%	68%
Gen Z	73%	65%

USANA Health Sciences, Inc. (USNA) - Análisis de mortero: factores tecnológicos

Tecnologías de fabricación avanzadas mejorando la calidad y consistencia del producto

USANA invirtió $ 14.2 millones en actualizaciones de tecnología de fabricación en 2022. La compañía utiliza equipos de fabricación automatizados de alta precisión con una precisión de control de calidad del 99.7%. Sus instalaciones de fabricación son certificadas ISO 9001: 2015, que emplean tecnologías de producción avanzadas de grado farmacéutico.

Inversión tecnológica	Gasto 2022	Precisión de fabricación
Actualizaciones de tecnología de fabricación	$ 14.2 millones	99.7% de precisión de control de calidad
Líneas de producción automatizadas	8 líneas de producción completas	ISO 9001: 2015 certificado

Plataformas digitales que mejoran la venta directa y la participación del cliente

La plataforma digital de USANA generó $ 127.3 millones en ventas en línea durante 2022, lo que representa el 22.5% de los ingresos totales de la compañía. La plataforma de participación digital de la compañía admite 250,000 distribuidores independientes activos a nivel mundial.

Métricas de plataforma digital	Rendimiento 2022
Ingresos de ventas en línea	$ 127.3 millones
Porcentaje de ingresos totales	22.5%
Distribuidores independientes activos	250,000

Inversión en comercio electrónico y desarrollo de aplicaciones móviles

USANA asignó $ 6.7 millones para el comercio electrónico y el desarrollo de aplicaciones móviles en 2022. Su aplicación móvil admite el seguimiento de ventas en tiempo real, con 175,000 usuarios mensuales activos y una calificación de usuario de 4.6/5.

Inversión de comercio electrónico	Detalles de 2022
Gasto de desarrollo tecnológico	$ 6.7 millones
Aplicación móvil usuarios activos mensuales	175,000
Calificación del usuario de la aplicación móvil	4.6/5

Tecnologías emergentes en ciencias nutricionales y formulación de suplementos

USANA invirtió $ 9.3 millones en investigación y desarrollo para la ciencia nutricional avanzada en 2022. La compañía mantiene 12 patentes activas relacionadas con la formulación de suplementos y la tecnología nutricional.

Investigación y desarrollo	2022 estadísticas
Inversión de I + D	$ 9.3 millones
Patentes activas	12 patentes
Áreas de enfoque de investigación	Ciencia nutricional, formulación de suplementos

USANA Health Sciences, Inc. (USNA) - Análisis de mortero: factores legales

Cumplimiento de las regulaciones internacionales de suplementos dietéticos

USANA Health Sciences opera bajo estrictos marcos regulatorios en múltiples jurisdicciones. A partir de 2024, la compañía mantiene el cumplimiento de los organismos regulatorios clave:

Cuerpo regulador	Estado de cumplimiento	Requisitos reglamentarios clave
FDA (Estados Unidos)	Totalmente cumplido	Regulaciones de DSHEA
Salud de Canadá	Certificado	Regulaciones de productos de salud natural
TGA (Australia)	Registrado	Ley de bienes terapéuticos

Riesgos de litigios continuos en el modelo de negocio de venta directa

Exposición de litigios de USANA a partir de 2024:

Categoría de litigio	Número de casos activos	Gastos legales estimados
Disputas del distribuidor	7	$ 1.2 millones
Reclamaciones de responsabilidad del producto	3	$750,000
Investigaciones regulatorias	2	$450,000

Protección de propiedad intelectual para formulaciones de suplementos propietarios

Portafolio de propiedad intelectual de USANA:

• Patentes activas totales: 22
• Aplicaciones de patentes pendientes: 8
• Registros de marca registrada: 45 a nivel mundial

Categoría de IP	Jurisdicción de protección	Año de registro
Patente de formulación nutricional	Estados Unidos	2019
Tecnología de nutrición celular	unión Europea	2020

Adherencia a los estándares globales de cumplimiento de marketing y publicidad

Métricas de cumplimiento para regulaciones de marketing:

Área de cumplimiento regulatorio	Tasa de cumplimiento	Resultados de auditoría anual
Pautas de publicidad de FTC	98.5%	Sin violaciones importantes
Estándares de marketing internacional	97.3%	Acciones correctivas menores

USANA Health Sciences, Inc. (USNA) - Análisis de mortero: factores ambientales

Aumento del enfoque en el abastecimiento sostenible de ingredientes nutricionales

USANA Health Sciences se ha comprometido con el abastecimiento de ingredientes sostenibles con métricas específicas:

Categoría de ingredientes	Porcentaje de abastecimiento sostenible	Inversión anual
Vitaminas	62%	$ 3.2 millones
Minerales	55%	$ 2.7 millones
Extractos botánicos	47%	$ 1.9 millones

Reducción de la huella de carbono en los procesos de fabricación y distribución

Las iniciativas de reducción de carbono de USANA incluyen:

• Reducido el consumo de energía de fabricación en un 18,5%
• Fuentes de energía renovables implementadas que cubren el 22% de las necesidades de energía total
• Las emisiones de carbono reducidas por 14.3 toneladas métricas en 2023

Proceso	Mejora de la eficiencia energética	Ahorro de costos
Fabricación	18.5%	$ 1.6 millones
Distribución	12.7%	$890,000

Creciente demanda del consumidor de envases de productos ambientalmente responsables

Métricas de sostenibilidad del embalaje:

Tipo de embalaje	Porcentaje reciclable	Inversión de envasado anual
Embalaje principal	76%	$ 2.4 millones
Embalaje secundario	65%	$ 1.1 millones

Implementación de iniciativas verdes en estrategias de sostenibilidad corporativa

Inversiones de Iniciativa Green Corporate:

Iniciativa	Inversión anual	Impacto ambiental
Conservación del agua	$750,000	Reducción del 22% en el uso del agua
Reducción de desechos	$680,000	31% de reducción del flujo de residuos
Tecnología verde	$ 1.2 millones	Implementó 3 nuevas tecnologías sostenibles

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Social factors

You're looking at USANA Health Sciences, Inc. (USNA) and seeing a company in the middle of a major social and operational pivot. The direct selling model is under pressure, so the firm is strategically shifting its focus toward a younger, more entrepreneurial demographic while simultaneously buying into the high-growth, clean-label children's wellness market. This is a necessary, albeit painful, transition to stabilize their customer base.

Shift in customer base

The core challenge is clear: the traditional direct selling customer base is shrinking. In the third quarter of 2025 (Q3 2025), the number of Direct Selling Active Customers dropped to 388,000, a significant decline from the 452,000 reported in the same period of 2024. This 14% year-over-year reduction in active participants puts pressure on the traditional multi-level marketing (MLM) structure. To be fair, part of this softness was attributed to a temporary slowdown in productivity as the new compensation plan was rolled out in Q3 2025, but the underlying trend of a declining base is defintely a social headwind.

Metric	Q3 2025 Value	Q3 2024 Value	Change
Direct Selling Active Customers	388,000	452,000	-14%
Q3 Net Sales (Direct Selling)	$183 million (est.)	$200 million	-8.5% (est.)

The strategic pivot to 'Brand Partners' aims to attract a younger, entrepreneurially-minded demographic.

USANA is actively trying to modernize its social appeal by rebranding its distributors as 'Brand Partners' and overhauling its compensation plan. This enhanced plan, rolled out in Q3 2025, is a direct response to the social demand for more flexible, digitally-integrated, and transparent earning opportunities. It's a move to attract younger individuals who see themselves as online entrepreneurs rather than traditional door-to-door salespeople. The goal is to drive long-term success in a competitive landscape by focusing on upfront earnings opportunities and clearer career progression, which resonates well with the millennial and Gen Z desire for immediate, measurable results.

• Modernize the business model for the digital age.
• Offer improved, more immediate earning opportunities.
• Encourage re-engagement from longer-tenured Brand Partners.

The acquisition of Hiya Health Products taps into the high-growth children's wellness and clean-label supplement trend.

The December 2024 acquisition of a 78.8% controlling stake in Hiya Health Products for $205 million is a brilliant strategic move to diversify away from the core direct selling channel and tap into powerful social trends. Hiya is a direct-to-consumer (DTC) brand focused on children's health, which is a segment prioritizing clean-label (minimal, recognizable ingredients) and subscription models. This is a massive social shift in consumer preference. For the full fiscal year 2025, Hiya's net sales growth is anticipated to approach 30% year-over-year, and in Q3 2025 alone, Hiya generated $31 million in net sales with 193,400 active monthly subscribers. That's a strong, profitable growth engine that speaks to modern parental health concerns.

USANA is the No. 1 dietary supplements brand in the Philippines for seven consecutive years (2019-2025), showing strong regional brand loyalty.

Despite the challenges in its core market, USANA maintains exceptional brand loyalty in key international regions. The company was recognized by Euromonitor International as the No. 1 dietary supplements brand in the Philippines for the seventh consecutive year, spanning 2019 through 2025. This sustained leadership, announced in November 2025, demonstrates that the brand's commitment to science-based nutrition and quality products still holds immense social capital and consumer trust in certain Asia Pacific markets. This regional strength is a crucial buffer against the domestic pivot risk, and it shows the power of a deeply established brand in a health-conscious culture.

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Technological factors

Integration of a new ERP (Enterprise Resource Planning) system is underway to drive efficiency, particularly for the Hiya business

The core technological focus for USANA Health Sciences in 2025 is on unifying the infrastructure following the acquisition of Hiya Health Products. This involves a critical integration of a new Enterprise Resource Planning (ERP) system, which is currently underway. This system upgrade is defintely a necessary move to streamline operations, especially for the high-growth Hiya segment, which operates on a different model than the core direct sales business.

The goal is to drive significant operational efficiencies and improve margins by standardizing processes across the two business models. Plus, the company is integrating a new logistics partner alongside the ERP implementation to optimize the supply chain. This effort is key to handling the rapid scaling of the direct-to-consumer (DTC) volume that Hiya is generating.

Hiya's direct-to-consumer (DTC) subscription model offers a scalable digital sales channel outside the traditional MLM structure

The Hiya acquisition, completed in late 2024, was a strategic technology play, giving USANA a proven, scalable digital sales channel outside its traditional multi-level marketing (MLM) structure. This direct-to-consumer subscription model provides a predictable revenue stream and strong customer relationships.

The financial impact in 2025 is substantial. Hiya's net sales for fiscal year 2025 are projected to be between $145 million and $160 million, representing a year-over-year growth rate of 29% to 42%. The business had 200,400 Active Monthly Subscribers as of the second quarter of 2025, demonstrating the power of the subscription technology model. That's a strong digital foothold.

Hiya DTC Business Metric	2025 Fiscal Year Data
Projected Net Sales (FY 2025)	$145 million - $160 million
Projected Year-over-Year Growth (FY 2025)	29% to 42%
Active Monthly Subscribers (Q2 2025)	200,400

Continued investment in R&D supports science-based product innovation, like the Celavive® skincare line

USANA maintains its commitment to science-based product development, which is a core technological advantage. The company invests a significant amount in research and development to ensure product efficacy. This R&D focus is immediately visible in the 2025 product refresh cycle.

In August and September 2025, USANA unveiled the next-generation Celavive skincare line, which included both new products and enhanced formulations. Here's the quick math on the product science:

• The Celavive Vitalizing Serum was reformulated with more than four times the active ingredients.
• A clinical study in April 2025 on the Celavive Resurfacing Serum showed a 15.8% reduction in the appearance of fine lines over a 12-week period.
• Other key metrics from the study included an 11.6% reduction in the appearance of pores and a 23% reduction in acute visible hyperpigmentation.

This kind of clinical data, backed by R&D, is crucial for maintaining credibility and driving sales in the competitive premium supplement and skincare markets.

The company is leveraging its manufacturing expertise to bring Hiya product production in-house, starting in late Q2 2026

A key technological and operational synergy identified post-acquisition is leveraging USANA's established manufacturing capabilities for the Hiya product line. The plan is to bring Hiya product production in-house, which is anticipated to begin in late Q2 2026.

This vertical integration is a direct application of USANA's existing technological and manufacturing expertise. The move is expected to generate operational efficiencies and, more importantly, lead to margin improvements in the second half of 2026. This decision to use internal capacity, rather than relying on third-party manufacturing, helps control quality and cost, which is a smart long-term action.

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Legal factors

Increased Federal Trade Commission (FTC) scrutiny on direct selling companies, especially concerning earnings claims, poses a compliance risk in the U.S.

The regulatory environment for direct selling companies like USANA Health Sciences, Inc. is tightening significantly in the U.S. The Federal Trade Commission (FTC) is pushing for an unprecedented level of oversight, specifically targeting misleading earnings claims (income representations) in the multi-level marketing (MLM) industry.

In January 2025, the FTC released a Notice of Proposed Rulemaking for a new Earnings Claim Rule that would require MLMs to maintain written substantiation for all earnings claims for at least three years and make that documentation available upon request. This is a massive administrative and legal burden. Honesty, the FTC's 2024 Staff Report already reviewed 70 Income Disclosure Statements (IDS) from MLM companies and found not even one to be compliant. This signals a near-zero tolerance for ambiguity in income disclosures going forward.

USANA must be defintely proactive. The company was already a recipient of a 2023 FTC Notice of Penalty Offenses concerning the substantiation of product claims, which puts them on the regulator's radar for potential civil penalties if future conduct is found to be deceptive. The new rule, if finalized, would allow the FTC to seek civil penalties and consumer refunds, which was previously limited.

Regulatory compliance is critical in Mainland China, where direct sales are subject to strict government approval and oversight.

Mainland China remains USANA's largest market, and its legal structure is complex. Direct selling is governed by a strict government approval system, and the core direct selling license approval system is not expected to change, even with other regulatory revisions. USANA operates there through its subsidiary, BabyCare Holdings, Ltd., which has seen sequential net sales growth of 6% in Q1 2025.

The major legal risk is a lack of explicit, blanket approval. BabyCare has not received official government approval that its business model or compensation plan fully complies with all applicable direct selling laws and regulations. This means the company is technically operating in a gray area, relying on its multi-channel strategy (online sales, retail branches) to mitigate risk.

Here's the quick math: USANA's total consolidated net sales for Q1 2025 were $250 million. A significant regulatory disruption in China-which is a huge revenue driver-would immediately impact the full-year 2025 net sales guidance of $775 million to $840 million for the direct selling business. Also, a pilot program for multi-level direct selling is being considered for select licensed companies, which could be a huge opportunity for USANA if they are chosen, but it adds another layer of regulatory uncertainty.

The company must manage data privacy law changes, particularly in its large Asian markets.

The Asia-Pacific region is rapidly maturing its data privacy laws in 2025, creating a patchwork of compliance requirements that USANA must navigate for its millions of customers and distributors. This is a global problem, but it's particularly acute for USANA given its large customer base in markets like China, South Korea, and the Philippines.

Key new or enhanced regulations that impact USANA include:

• China's Network Data Security Management Regulations: Effective January 1, 2025, these regulations clarify compliance and impose new restrictions on cross-border data transfers.
• India's Digital Personal Data Protection (DPDP) Act: Expected to be fully effective in 2025, this law introduces explicit consent requirements and data localization mandates.
• South Korea's Privacy Law Updates: Amendments are bringing higher fines for data breaches and stricter requirements for obtaining user consent.
• U.S. Data Security Program (DSP): Effective April 8, 2025, new DOJ rules restrict the transfer of bulk U.S. sensitive personal data-even de-identified health data-to certain foreign countries, which may impact USANA's global data processing.

If USANA's systems fail to adapt to these new cross-border data transfer controls and consent requirements, the risk of significant financial penalties-like the potential fine of up to INR 250 crore (approximately $30 million USD) for non-compliance under India's DPDP Act-rises dramatically.

Maintaining Good Manufacturing Practices (GMP) certification is non-negotiable for product quality and legal standing globally.

For a health and wellness company, maintaining current Good Manufacturing Practices (GMP) is the legal foundation of product quality and is non-negotiable for selling products worldwide. USANA goes above the minimum standard by voluntarily modeling its quality assurance program on the more stringent pharmaceutical GMP (21 CFR, part 211), rather than just the dietary supplement GMP (21 CFR, part 111).

The company's primary manufacturing facility in Salt Lake City, Utah, holds certification from the United States Pharmacopeia (USP) and NSF International. This compliance is continuously audited and verified across all its global operations.

For example, in the Philippines, a key Asian market, USANA Health Sciences, Inc.'s manufacturing plant address has a current certificate validity date of November 14, 2026, confirming compliance with the local Food and Drug Administration (FDA) requirements for non-sterile products like tablets and capsules. This continuous, documented compliance is essential to avoid product recalls, import bans, and regulatory fines in the 25 international markets where USANA operates.

Regulatory Body / Standard	Scope of Compliance	USANA's Status / Key Date (2025)
U.S. Federal Trade Commission (FTC)	Earnings Claims & Product Substantiation	New Earnings Claim Rule proposed (Jan 2025); requires substantiation for 3 years.
Mainland China Direct Selling Law	Business Model & Compensation Plan	Subsidiary BabyCare has not received explicit full compliance approval; Q1 2025 China net sales grew 6% sequentially.
Philippines FDA (GMP)	Good Manufacturing Practices	Current certificate validity date is November 14, 2026.
China PIPL / Network Data Security	Data Privacy & Cross-Border Data Transfer	Network Data Security Management Regulations effective January 1, 2025; requires explicit consent.

Finance: draft a compliance cost estimate for implementing the new FTC Earnings Claim Rule substantiation requirements by the end of Q4 2025.

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Environmental factors

USANA Health Sciences, Inc. (USNA) has made its environmental stewardship a clear strategic priority, which is defintely a necessity in the current consumer and regulatory climate. The company's approach is grounded in measurable metrics, focusing on reducing its operational footprint in energy, waste, and packaging. This commitment acts as a key differentiator and mitigates the rising risk of regulatory scrutiny on manufacturing and supply chain sustainability.

Sustainability efforts are focused on three pillars: People, Planet, and Products, guiding long-term strategy.

The company structures its entire sustainability program around three core pillars: People, Planet, and Products. This framework ensures that environmental goals are not isolated but are integrated with social and product-focused initiatives, which is smart because it ties sustainability directly to the business mission-creating a healthier world. This is not just a marketing effort; it's a strategic imperative that drives innovation and resilience across the business.

For the 'Planet' pillar, the focus areas are clear and actionable:

• Waste Management: Reduce waste sent to landfills and streamline recycling efforts.
• GHG Management: Invest in renewable energy and reduce global Scope 1 and 2 emissions.
• Sustainable Packaging: Minimize the environmental impact of packaging and increase the use of lower-emission options.

The Salt Lake campus sources 58% of its energy from solar arrays and renewable energy certificates.

USANA's commitment to clean energy is evident at its Salt Lake City headquarters and manufacturing campus. As of the 2024 fiscal year reporting, 58% of the electric energy used at the HQ campus is sourced from renewable sources. This is achieved through a combination of on-site solar arrays and the purchase of Renewable Energy Certificates (RECs), demonstrating a tangible investment in decarbonization. This effort also contributed to a 17% reduction in global Scope 1 and 2 Greenhouse Gas (GHG) emissions year-over-year, which is a significant operational achievement.

Waste management is a priority, with 57% of operational waste diverted from landfills.

Effective waste management is a major component of the 'Planet' pillar. The company has made substantial progress in diverting waste from landfills, a critical metric for manufacturing operations. In the 2024 fiscal year, USANA successfully diverted 57% of its home office operational waste away from landfills, a strong performance that is well above many industry averages. Furthermore, the company reported a 33% year-over-year reduction in scrap waste, showing that efficiency gains are directly translating into environmental benefits.

The company is actively reducing packaging, saving the equivalent of 300,319 supplement bottles worth of plastic in 2024.

Packaging is a high-visibility environmental issue for consumer goods companies, and USANA is addressing it head-on. By moving to smaller bottles for select products, the company achieved a significant reduction in plastic use. This packaging change in 2024 resulted in saving the equivalent of over 300,319 supplement bottles worth of plastic from being diverted to landfills. They are also incorporating the How2Recycle smart labeling system onto Nutritionals packaging in qualified markets to help consumers with proper recycling, translating jargon into a clear action for the end-user. That's a clear win for both the planet and brand perception.

Here is a snapshot of USANA's key environmental performance metrics from the 2024 fiscal year, as reported in 2025:

Environmental Metric	2024 Fiscal Year Performance (Reported 2025)	Significance
Renewable Energy Use at Salt Lake Campus	58% of electric energy from renewable sources	Reduces reliance on non-renewable grid power.
Operational Waste Diversion Rate	57% of home office waste diverted from landfills	Minimizes landfill contribution and shows operational efficiency.
Global GHG Emissions Reduction (Scope 1 & 2)	Reduced by 17% year-over-year	Directly addresses climate change impact from operations.
Plastic Packaging Reduction	Equivalent of over 300,319 supplement bottles saved	Tangible reduction in virgin plastic use and waste volume.
Scrap Waste Reduction	Reduced by 33% year-over-year	Indicates improved manufacturing process efficiency.

Finance: Monitor the Q4 2025 earnings call for an update on the $4.7 million cost reduction charge and the Hiya integration timeline by year-end.